Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort Study

J Invest Dermatol. 2015 Oct;135(10):2394-2401. doi: 10.1038/jid.2015.197. Epub 2015 Jun 1.

Abstract

The genetic determinants of post-burn hypertrophic scarring (HTS) are unknown, and melanocortin 1 receptor (MC1R) loss-of-function leads to fibrogenesis in experimental models. To examine the associations between self-identified race and MC1R single-nucleotide polymorphisms (SNPs) with severity of post-burn HTS, we conducted a prospective cohort study of burned adults admitted to our institution over 7 years. Subjects were evaluated using the Vancouver Scar Scale (VSS), asked to rate their itching, and genotyped for 8 MC1R SNPs. Testing for association with severe HTS (VSS>7) and itch severity (0-10) was based on multivariate regression with adjustment for known risk factors. Of 425 subjects analyzed, 77% identified as White. The prevalence of severe HTS (VSS>7) was 49%, and the mean itch score was 3.9. In multivariate analysis, Asian (prevalence ratio (PR) 1.54; 95% CI: 1.13-2.10), Black/African American (PR 1.86; 95% CI: 1.42-2.45), and Native American (PR 1.87; 95% CI: 1.48-2.35) race were independently associated with severe HTS. MC1R SNP R163Q was also significantly (P<0.001) associated with severe HTS. Asian race (linear regression coefficient 1.32; 95% CI: 0.23-2.40) but not MC1R SNP genotype was associated with increased itch score. We conclude that MC1R genotype may influence post-burn scarring.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Burns / blood*
  • Burns / complications
  • Burns / therapy
  • Cicatrix, Hypertrophic / ethnology*
  • Cicatrix, Hypertrophic / etiology
  • Cicatrix, Hypertrophic / genetics*
  • Cicatrix, Hypertrophic / pathology
  • Cohort Studies
  • Female
  • Genotype
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Poisson Distribution
  • Polymorphism, Single Nucleotide*
  • Prevalence
  • Prospective Studies
  • Receptor, Melanocortin, Type 1 / genetics*
  • Risk Assessment
  • Severity of Illness Index
  • Wound Healing / genetics
  • Wound Healing / physiology

Substances

  • Receptor, Melanocortin, Type 1